I just spent the last four days in New York at the annual Integrative Health conference.
As per usual, some of the most important educational pearls are learned in the exhibit hall.
I spent some quality time talking with a Dr. Born, a naturopathic physician from Alameda, California. Dr. Born has been using a vaccinosis homeopathic nosode that he buys from a reputable manufacturer in California and has been able to measure IgG antibody levels in his patients within two months of administering it.
As you know, antibody levels are the holy grail of proof that a vaccination has worked and is the proof required by authorities to prove that a patient is safe to live in society.
We, in fact, have been using another nosode product from a different reputable manufacturer and have never suggested these measurements unless asked for by school systems or the military.
Previously, no one has ever reported such a phenomena of antibodies from a nosode and explain protection from passive protections at deeper levels.
I’m actually going to order the same nosode he was using and see if I can recreate his results in willing informed patients. It will require a blood test both before and after, as many patients also have existing immunity acquired by herd immunity simply by being around patients who transmit sub-clinical levels of virus after either being vaccinated or by being exposed to sick patients.
Please don’t forget that homeopathy was started as a result of the cowpox/smallpox phenomenon of the late 1700’s. The studies on those patients were the first homeopathic uses. We’ve been in the vaccination field since the beginning of vaccinations. I predict that it will take us at least two weeks to obtain this new product.
The other thing of interest to me was a new urine test for 8-OH-dG as a marker for inflammation. I’m going to recommend it for all of our chelation and ozone patients as the test is done by Doctor’s Data, the lab that tests for heavy metals. It will be a proof of efficacy for all of our IV procedures including our new phosphatidylcholine IVs.